![Lupin shares rise 4% on nod for Mirabegron tablets](https://images.assettype.com/fortuneindia%2F2022-09%2F10dc097a-75c0-4750-9176-60bac2de1d3d%2FLupin.jpg?w=300&q=95)
Lupin shares rise 4% on nod for Mirabegron tablets
Lupin has received U.S. FDA approval for Mirabegron Extended-Release Tablets used for the treatment of overactive bladder.
Lupin has received U.S. FDA approval for Mirabegron Extended-Release Tablets used for the treatment of overactive bladder.